How GCMI helps Georgia Tech faculty members convert research into innovative medical products – Our one-on-one interview with Dr. Omer Inan

GCMI’s foremost goal as an affiliate of the Georgia Institute of Technology is to partner with Georgia Tech faculty and engineers in the innovation process of new medical products. One successful example of this partnership has been our work with Dr. Scott Hollister. With GCMI’s help, Children’s Healthcare of Atlanta surgeons used Dr. Hollister’s process…

Is Getting New Treatments to Patients Harder Than Landing on Mars?

“Is Getting New Treatments to Patients Harder Than Landing on Mars?” Georgia Tech Research Horizons Senior Science Writer, Ben Brumfield, recently enlisted GCMI CEO, Tiffany Wilson, to help answer the question. According to the article, only 15% of new therapies make it to patients, and getting a new treatment to market can require $1 billion in pharmaceutical company investment, “more than the entire budget for the latest NASA Mars mission.” 

Join GCMI as we take a look into the future of spine therapy innovation at NASS 2019

The North American Spine Society (NASS) Annual Meeting is the gathering with arguably the greatest ability to influence the global market for spinal implants and devices, its innovation and growth. T3 Labs Orthopedic Program Director Dr. Evan Goldberg, a long-time veteran of this industry-leading spine conference, will be onsite at NASS 2019 in Chicago on September 25-28.

Looking to engage an Industry Leading Preclinical CRO? Connect with T3 Labs at TCT 2019!

The Transcatheter Cardiovascular Therapeutics (TCT) meeting is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year, it will take place on September 25-29, 2019 in San Francisco, California. GCMI and T3 Labs will be attending as an exhibitor at TCT again this year, and our booth number is A2118.

Discussing Commercialization and Investment Strategies at the Annual MedTech Conference

The annual AdvaMed MedTech Conference, the leading medtech industry conference in North America, will once again bring together over 3,000 attendees from across the world on September 23–25 to network and share insights. GCMI CEO, Tiffany Wilson, is excited to join this group of industry professionals in Boston and to participate in one of the featured sessions at this year’s event. 

Need help moving a medtech device through development and regulatory pathways? Connect with T3 Labs at ASAIO 2019.

At GCMI, medtech and medical device innovation are at the core of our efforts including our work within our industry leading preclinical CRO. While our team constantly focuses on the advancement of our sponsors’ journeys from concept to commercialization to cure, we actively seek to attend events that connect us with medtech innovators across the…

GCMI and Rambam Medical Center Accelerator Evaluating 12 Israeli Startups for U.S. Commercialization.

In October 2018, GCMI and Rambam Medical Center announced the formation of a partnership to help Israeli medtech innovators commercialize their products in the U.S. healthcare market. Earlier this year, Georgia Bio and the Atlanta Chamber of Commerce recognized our work with a 2019 Phoenix Award recognizing leaders who have forged academic and industry relationships…